Company news

Kane Biotech Inc. news in 2026

Kane Biotech Inc.'s news releases, calls and decks from 2026, newest first.

View company

Kane Announces Publication of Real-World Evidence in the International Wound Journal

November 4, 2026

Kane Engages Independent Trading Group as Market Maker

October 21, 2026

Kane Biotech Signs Distribution Agreement with The Stevens Company

October 20, 2026

Kane to Showcase revyve® at Wounds Canada National Hybrid Conference

October 19, 2026

Kane Launches New Corporate Brand and Redesigned Website

October 19, 2026

Kane Biotech Announces $250,000 Insider Loan

October 16, 2026

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

October 7, 2026

Kane Biotech to Host Commercial Update Webcast on September 16

September 9, 2026

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

September 2, 2026

Kane Biotech Announces Second Quarter 2026 Financial Results

August 27, 2026

Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium

August 25, 2026

Kane Biotech Announces Engagement of DNA Advisors

August 5, 2026

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

July 2, 2026

Kane Biotech Announces Grant of Stock Options

May 29, 2026

Kane Biotech Announces First Quarter 2026 Financial Results

May 28, 2026

Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering

May 26, 2026

Kane Biotech Presents Data To Global Wound Care Community at WCET®-NSWOCC® 2026 Joint Congress

May 13, 2026

Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results

April 23, 2026

Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference

April 16, 2026

Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms

March 17, 2026

Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

March 10, 2026

Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal

February 20, 2026

Kane Biotech Expands Commercial Activities in the United States

February 19, 2026

Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser

February 17, 2026

Kane Biotech Restarts Commercial Activities and Strengthens North American Management

February 12, 2026

Decks in 2026